PacBio to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

PacBio (NASDAQ: PACB) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 14 at 1:30 p.m. Eastern Time. A fireside chat with management will be accessible via a live webcast on the company's investor page. The event will conclude with a replay available for 30 days. PacBio is known for its advanced sequencing solutions, addressing complex genetic research across various applications, including oncology and infectious diseases. For more details, visit www.pacb.com.

MENLO PARK, Calif., Sept. 7, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York.

Members of PacBio's management are scheduled to participate in a fireside chat on Wednesday, September 14 at 1:30 p.m. Eastern Time. The live webcast can be accessed at the company's investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the presentation.

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB™ short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacb.com 

Media:
Lizelda Lopez
pr@pacb.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference-301619599.html

SOURCE Pacific Biosciences of California, Inc.

FAQ

When will PacBio participate in the Morgan Stanley Global Healthcare Conference?

PacBio will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 14 at 1:30 p.m. Eastern Time.

Where can I watch the PacBio presentation at the Morgan Stanley conference?

The PacBio presentation can be accessed via a live webcast on the company's investor page at investor.pacificbiosciences.com.

How long will the webcast of PacBio's presentation be available?

The replay of the webcast will be available for at least 30 days following the presentation.

What is the focus area of PacBio's technology?

PacBio focuses on high-quality, highly accurate sequencing solutions for human genome sequencing, oncology, and microbiology among other areas.

What is the stock symbol for PacBio?

The stock symbol for PacBio is PACB, listed on NASDAQ.